Sauer, B. & Henderson, N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85(14), 5166–5170 (1988).
Metzger, D. et al. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92(15), 6991–6995 (1995).
Kwan, K. M. Conditional alleles in mice: Practical considerations for tissue-specific knockouts. Genesis 32(2), 49–62 (2002).
Kühn, R. & Wurst, W. Gene knockout protocols. 2nd ed. In Methods in molecular biology, xvi, 4 p. of plates (Humana Press, 2009).
Zhong, Z. A. et al. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Bone 81, 614–619 (2015).
Elrashidy, R. A. et al. Smooth muscle-specific deletion of MnSOD exacerbates diabetes-induced bladder dysfunction in mice. Am. J. Physiol. Renal Physiol. 317(4), F906–F912 (2019).
Liang, C. C. et al. Transgenic mice exhibiting inducible and spontaneous Cre activities driven by a bovine keratin 5 promoter that can be used for the conditional analysis of basal epithelial cells in multiple organs. J. Biomed. Sci. 16, 2 (2009).
Bu, F. et al. Activation of neuronal Ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and axonal plasticity in mice. J. Neurochem. https://doi.org/10.1111/jnc.15195 (2020).
Benedykcinska, A. et al. Generation of brain tumours in mice by Cre-mediated recombination of neural progenitors in situ with the tamoxifen metabolite endoxifen. Dis. Model Mech. 9(2), 211–220 (2016).
Feil, S., Valtcheva, N. & Feil, R. Inducible Cre mice. Methods Mol. Biol. 530, 343–363 (2009).
Whitfield, J. et al. The estrogen receptor fusion system in mouse models: A reversible switch. Cold Spring Harb. Protoc. 2015(3), 227–234 (2015).
Elefteriou, F. & Yang, X. Genetic mouse models for bone studies–strengths and limitations. Bone 49(6), 1242–1254 (2011).
Lin, C. et al. Alveolar type II cells possess the capability of initiating lung tumor development. PLoS ONE 7(12), e53817 (2012).
Metzger, D. & Chambon, P. Site- and time-specific gene targeting in the mouse. Methods 24(1), 71–80 (2001).
Seime, T. et al. Inducible cell labeling and lineage tracking during fracture repair. Dev. Growth Differ. 57(1), 10–23 (2015).
Samsonraj, R. M. et al. A versatile protocol for studying calvarial bone defect healing in a mouse model. Tissue Eng. Part C Methods 23(11), 686–693 (2017).
Wilk, K. et al. Postnatal calvarial skeletal stem cells expressing PRX1 Reside exclusively in the calvarial sutures and are required for bone regeneration. Stem Cell Rep. 8(4), 933–946 (2017).
Lo Celso, C. et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457(7225), 92–96 (2009).
Karsenty, G. & Mera, P. Molecular bases of the crosstalk between bone and muscle. Bone 115, 43–49 (2018).
D’Amelio, P. & Sassi, F. Gut microbiota, immune system, and bone. Calcif. Tissue Int. 102(4), 415–425 (2018).
Karsenty, G. Update on the biology of osteocalcin. Endocr. Pract. 23(10), 1270–1274 (2017).
Grueneberg, D. A. et al. Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science 257(5073), 1089–1095 (1992).
Kawanami, A. et al. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem. Biophys. Res. Commun. 386(3), 477–482 (2009).
Bassir, S. H. et al. Prx1 expressing cells are required for periodontal regeneration of the mouse incisor. Front. Physiol. 10, 591 (2019).
Martin, J. F. & Olson, E. N. Identification of a prx1 limb enhancer. Genesis 26(4), 225–229 (2000).
Xiong, J. et al. Matrix-embedded cells control osteoclast formation. Nat. Med. 17(10), 1235–1241 (2011).
Lindhorst, A., Bechmann, I. & Gericke, M. Unspecific DNA recombination in AdipoqCre-ER(T2)—mediated knockout approaches in transgenic mice is sex-, age- and genotype-dependent. Adipocyte 9(1), 1–6 (2020).
Christodoulou, C. et al. Live-animal imaging of native haematopoietic stem and progenitor cells. Nature 578(7794), 278–283 (2020).
Yeh, S. A. et al. In Vivo 3D histomorphometry quantifies bone apposition and skeletal progenitor cell differentiation. Sci. Rep. 8(1), 5580 (2018).
Miao, H. & Xiao, C. Simultaneous segmentation of leukocyte and erythrocyte in microscopic images using a marker-controlled watershed algorithm. Comput. Math. Methods Med. 2018, 7235795 (2018).
Onaciu, A. et al. Spontaneous and induced animal models for cancer research. Diagnostics 10(9), 660 (2020).
Maurel, D. B. et al. Characterization of a novel murine Sost ER(T2) Cre model targeting osteocytes. Bone Res. 7, 6 (2019).
Jahn, H. M. et al. Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia. Sci. Rep. 8(1), 5913 (2018).
Donocoff, R. S. et al. Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations. Sci. Rep. 10(1), 15244 (2020).
Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244(2), 305–318 (2002).
Jones, T. & Jones, P. L. A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. PLoS ONE 13(2), e0192657 (2018).
Avci, P. et al. Animal models of skin disease for drug discovery. Expert Opin. Drug Discov. 8(3), 331–355 (2013).
Bosenberg, M. et al. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 44(5), 262–267 (2006).
Vasioukhin, V. et al. The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl. Acad. Sci. USA 96(15), 8551–8556 (1999).
Zadelaar, S. M. et al. Local Cre-mediated gene recombination in vascular smooth muscle cells in mice. Transgenic Res. 15(1), 31–36 (2006).
Pimeisl, I. M. et al. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line. Genesis 51(10), 725–733 (2013).
Reid, J. M. et al. Pharmacokinetics of endoxifen and tamoxifen in female mice: Implications for comparative in vivo activity studies. Cancer Chemother. Pharmacol. 74(6), 1271–1278 (2014).
Higashi, A. Y. et al. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J. Immunol. 182(9), 5633–5640 (2009).
Takebayashi, H. et al. Tamoxifen modulates apoptosis in multiple modes of action in CreER mice. Genesis 46(12), 775–781 (2008).
Brash, J. T. et al. Tamoxifen-activated CreERT impairs retinal angiogenesis independently of gene deletion. Circ Res. 127(6), 849–850 (2020).
Julien, A. et al. FGFR3 in periosteal cells drives cartilage-to-bone transformation in bone repair. Stem Cell Rep. 15(4), 955–967 (2020).
Esposito, A. et al. Role of Prx1-expressing skeletal cells and Prx1-expression in fracture repair. Bone 139, 115521 (2020).
Youngstrom, D. W. et al. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice. Bone 91, 64–74 (2016).
Moore, E. R. et al. Periosteal progenitors contribute to load-induced bone formation in adult mice and require primary cilia to sense mechanical stimulation. Stem Cell Res. Ther. 9(1), 190 (2018).
Moore, E. R. et al. Correction to: Periosteal progenitors contribute to load-induced bone formation in adult mice and require primary cilia to sense mechanical stimulation. Stem Cell Res. Ther. 9(1), 229 (2018).
Yee, C. S. et al. Conditional deletion of Sost in MSC-derived lineages identifies specific cell-type contributions to bone mass and B-cell development. J. Bone Miner. Res. 33(10), 1748–1759 (2018).
Xiong, J., Almeida, M. & O’Brien, C. A. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone 112, 1–9 (2018).
Duchamp de Lageneste, O. et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat. Commun. 9(1), 773 (2018).
Cabahug-Zuckerman, P. et al. Site-specific load-induced expansion of Sca-1(+)Prrx1(+) and Sca-1(-)Prrx1(+) cells in adult mouse long bone is attenuated with age. JBMR Plus 3(9), e10199 (2019).
Deng, Q. et al. Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/beta-Catenin. Elife 8, e50208 (2019).
Green, A. C. et al. Retinoic acid receptor gamma activity in mesenchymal stem cells regulates endochondral bone, angiogenesis, and B lymphopoiesis. J. Bone Miner. Res. 33(12), 2202–2213 (2018).